Puma Biotechnology
PBYI
PBYI
136 hedge funds and large institutions have $1.41B invested in Puma Biotechnology in 2017 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7.87% more ownership
Funds ownership: 94.87% → 102.74% (+7.9%)
6% more funds holding
Funds holding: 128 → 136 (+8)
9% less call options, than puts
Call options by funds: $16.8M | Put options by funds: $18.5M
Holders
136
Holding in Top 10
2
Calls
$16.8M
Puts
$18.5M
Top Buyers
| 1 | +$64.6M | |
| 2 | +$28.7M | |
| 3 | +$24.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$21.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.5M |
Top Sellers
| 1 | -$34.4M | |
| 2 | -$16.6M | |
| 3 | -$16.6M | |
| 4 |
Citigroup
New York
|
-$5.32M |
| 5 |
JP
Jana Partners
New York
|
-$4.38M |